HSP90AB1 and B-cell chronic lymphocytic leukemia: In leukemia, HSP90 has been shown to bind to LYN in B-chronic lymphoblastic leukemia (B-CLL) and the use of 17-AAG destabilized the binding of HSP90-LYN in vitro, initiating cell apoptosis45.